SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Ternes TA, Stumpf M, Mueller J, Haberer K, Wilken RD, Servos M. 1999. Behaviour and occurrence of estrogens in municipal sewage treatment plants I. Investigations in Germany, Canada and Brazil. Sci Total Environ 225: 8190.
  • 2
    Kim SD, Jaeweon C, Kim IS, Vanderford BJ, Snyder SA. 2007. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking and waste waters. Water Res 41: 10131021.
  • 3
    Braga O, Smythe GA, Schaefer AI, Feitz AJ. 2005. Steroid estrogens in ocean sediments. Chemosphere 61: 827833.
  • 4
    Holbrook RD, Novak JT, Grizzard TJ, Love NG. 2002. Estrogen receptor agonist fate during wastewater and biosolids treatment processes: A mass balance analysis. Environ Sci Technol 36: 45334539.
  • 5
    Fent K, Weston A, Caminada D. 2006. Ecotoxicology of human pharmaceuticals—Review. Aquat Toxicol 76: 122159.
  • 6
    Ellis RJ, van den Heuvel MR, Bandelj E, Smith MA, McCarthy LH, Struthridge TR, Dietrich DR. 2003. In vivo and in vitro assessment of the androgenic potential of a pulp and paper mill effluent. Environ Toxicol Chem 22: 14481456.
  • 7
    Vethaak DA, Lahr J, Marca Schrap S, Belfroid AC, Rijs GBJ, Gerritsen A, de Boer J, Bulder AS, Grinwis GCM, Kuiper RV, Legler J, Murk TAJ, Peijnenburg W, Verhaar HJM, de Voogt P. 2005. An integrated assessment of estrogenic contamination and biological effects in the aquatic environment of the Netherlands. Chemosphere 59: 511524.
  • 8
    Qin JJ, Kekre KA, Tao G, Oo MH, Wai MN, Lee TC, Viswanath B, Seah H. 2006. New option of MBR-RO process for production of NEWater from domestic sewage. J Membr Sci 272: 7077.
  • 9
    Daude D, Stephenson T. 2003. Cost-effective treatment solutions for rural areas: Design and operation of a new package treatment plant for single households. Water Sci Technol 48: 107114.
  • 10
    Urase T, Kagawa C, Kikuta T. 2005. Factors affecting removal of pharmaceutical substances and estrogens in membrane separation bioreactors. Desalination 178: 107113.
  • 11
    Clara M, Strenn B, Gans O, Martinez E, Kreuzinger N, Kroiss H. 2005. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res 39: 47974807.
  • 12
    Kimura K, Hara H, Watanabe Y. 2005. Removal of pharmaceutical compounds by submerged membrane bioreactors (MBRs). Desalination 178: 135140.
  • 13
    Spring AJ, Bagley DM, Andrews RC, Lemanik S, Yang P. 2007. Removal of endocrine disruptors using a membrane bioreactor and disinfection. J Environ Eng Sci 6: 131139.
  • 14
    Coleman HM, Khan S, Watkins G, Stuetz R. 2007. Fate and analysis of endocrine disrupting chemicals in some sewage treatment plants in Australia. Water Sci Technol 58: 21872194.
  • 15
    Hu JY, Chen X, Tao G, Kekred K. 2007. Fate of endocrine disrupting compounds in membrane bioreactor systems. Environ Sci Technol 41: 40974102.
  • 16
    Ternes TA, Bonerz M, Herrmann N, Loeffler D, Keller E, Lacida BB, Alder AC. 2005. Determination of pharmaceuticals, iodinated contrast media and fragrances in sludge by LC/tandem MS and GC/MS. J Chromatogr A 1067: 213223.
  • 17
    Routledge EJ, Sumpter JP. 1996. Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environ Toxicol Chem 15: 241248.
  • 18
    Kirk LA, Tayler CR, Lye CM, Sumpter JP. 2002. Changes in estrogenic and androgenic activities at different stages of treatment in wastewater treatment works. Environ Toxicol Chem 21: 972979.
  • 19
    Leusch FDL, Chapman HF, van den Heuvel MR, Tan BLL, Gooneratne SR, Tremblay LA. 2006. Bioassay-derived androgenic and estrogenic activity in municipal sewage in Australia and New Zealand. Ecotoxicol Environ Saf 65: 403411.
  • 20
    Drewes JE, Hemming JH, Ladenburger SJ, Schauer J, Sonzogni W. 2005. An assessment of endocrine disrupting activity changes during wastewater treatment through the use of bioassays and chemical measurements. Water Environ Res 77: 1223.
  • 21
    Jenkins R, Angus RA, McNatt H, Howell WM, Kemppainen JA, Kirk M, Wilson, EM. 2001. Identification of androstenedione in a river containing paper mill effluent. Environ Toxicol Chem 20: 13251331.
  • 22
    Radjenovic J, Petrovic M, Barcelo M. 2007. Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor. Anal Bioanal Chem 387: 365377.
  • 23
    Lee HB, Peart TE, Lewina Svoboda M. 2005. Determination of endocrine disrupting phenols, acidic pharmaceuticals and personal care products in sewage by solid-phase extraction and gas chromatography-mass spectrometry. J Chromatogr A 1094: 122129.
  • 24
    Al-Rifai JH, Gabelish CL, Schafer AI. 2007. Occurrence of pharmaceutically active and non-steroidal estrogenic compounds in three different wastewater recycling schemes in Australia. Chemosphere 69: 803815.
  • 25
    Khan SJ, Ongerth JE. 2004. Modelling of pharmaceutical residues in Australian sewage by quantities of use and fugacity calculations. Chemosphere 54: 355367.
  • 26
    Joss A, Keller E, Alder AC, Goebel A, McArdell C, Ternes T. 2005. Removal of pharmaceuticals and fragrances in biological waste water treatment. Water Res 39: 31393152.
  • 27
    Synder SA, Adham S, Redding AM, Cannon FS, DeCarolis J, Oppenheimer J, Wert EC, Yoon Y. 2007. Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceuticals. Desalination 202: 156181.
  • 28
    Nakada N, Tanishima T, Shinohara H, Kiri K, Takada H. 2006. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Res 40: 32973303.
  • 29
    Stasinakis AS, Petalas AV, Mamais D, Thomaidis NS, Gatidou G, Themistokles DL. 2007. Investigation of triclosan fate and toxicity in continuous-flow activated sludge systems. Chemosphere 68: 375381.
  • 30
    Quintana JB, Rodil R, Muniategui-Lorenzo S, López-Mahia P, Prada-Rodriguez D. 2007. Multiresidue analysis of acidic and polar organic contaminants in water samples by stir-bar sorptive extraction-liquid desorption-gas chromatography-mass spectrometry. J Chromatogr A 1174: 2739.
  • 31
    Céspedes R, Lacorte S, Ginebreda A, Barceló D. 2008. Occurrence and fate of alkylphenols and alkylphenol ethoxylates in sewage treatment plants and impact on receiving waters along the Ter River (Catalonia, NE Spain). Environ Pollut 153: 384392.
  • 32
    Bolz U, Hagenmaier H, Körner W. 2001. Phenolic xenoestrogens in surface water, sediments, and sewage sludge from Baden-Wuerttemberg, south-west Germany. Environ Pollut 115: 291301.
  • 33
    Martin BirkettJW, LesterJN, eds. 2003. Endocrine Disrupters in Wastewater and Sewage Sludge. IWA Publishing, London, UK.
  • 34
    Reif R, Suárez S, Omil F, Lema JM. 2008. Fate of pharmaceuticals and cosmetic ingredients during the operation of a MBR treating sewage. Desalination 221: 511517.
  • 35
    Bendz D, Paxéus NA, Ginn TR, Loge FJ. 2005. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. J Hazard Mater 122: 195204.
  • 36
    Gomez MJ, Martinez Buen MJ, Lacorte S, Fernandez-Alba AR, Aguera A. 2007. Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. Chemosphere 66: 9931002.
  • 37
    Daughton CG, Ternes TA. 1999. Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environ Health Perspect 107(Suppl. 6):907.
  • 38
    Khan SJ, Ongerth JE. 2005. Occurrence and removal of pharmaceuticals at an Australian sewage treatment plant. Water 32: 8085.
  • 39
    Tan BLL, Hawker DA, Mueller JF, Tremblay LA, Chapman HF. 2008. Stir bar sorptive extraction and trace analysis of selected endocrine disruptors in water, biosolids and sludge samples by thermal desorption with gas chromatography-mass spectrometry. Water Res 42: 404412.
  • 40
    Ternes TA, Stumpf M, Mueller J. 1999. Behaviour and occurrence of estrogens in municipal sewage treatment plants II—Aerobic batch experiments with activated sludge. Sci Total Environ 225: 9099.
  • 41
    Braga O, Smythe GA, Schaefer AI, Feitz AJ. 2005. Fate of steroid estrogens in Australian inland and coastal wastewater treatment plants. Environ Sci Technol 39: 33513358.
  • 42
    Johnson AC, Sumpter JP. 2001. Removal of endocrine-disrupting chemicals in activated sludge treatment works. Environ Sci Technol 35: 46974703.
  • 43
    Carballa M, Omila F, Lema JM, Llompart M, Garcia-Jares C, Rodriguez I, Gomez M, Ternes T. 2004. Behaviour of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 38: 29182926.
  • 44
    Koh YK, Chiu TY, Boobis A, Cartmell E, Lester JN, Scrimshaw MD. 2007. Determination of steroid estrogens in wastewater by high performance liquid chromatography-tandem mass spectrometry. J Chromatogr A 1173: 8187.
  • 45
    Servos MR, Bennie DT, Burnison BK, Jurkovich A, McInnis R, Neheli T, Schnell A, Seto P, Smyth SA, Ternes TA. 2005. Distribution of estrogens 17β-estradiol and estrone in Canadian municipal wastewater treatment plants. Sci Total Environ 336: 155170.
  • 46
    Hohenblum P, Gans O, Moche W, Scharf S, Lorbeer G. 2004. Monitoring of selected estrogenic hormones and industrial chemicals in groundwaters and surface waters in Austria. Sci Total Environ 333: 185193.
  • 47
    Soto AM, Calabro JM, Prechtl NV, Yau AY, Orlande EF, Daxenberger A, Kolok AS, Guillette LJ, le Bizec B, Lange IG, Sonnenschein C. 2004. Androgenic and estrogenic activity in water bodies receiving cattle feedlot effluent in Eastern Nebraska, USA. Environ Health Perspect 112: 346352.
  • 48
    Salste L, Leskinen P, Virta M, Kronberg L. 2007. Determination of estrogens and estrogenic activity in wastewater effluent by chemical analysis and the bioluminescent yeast assay. Sci Total Environ 378: 343351.
  • 49
    Onda K, Nakamura Y, Takatoh C, Miya A, Katsu Y. 2003. The behaviour of estrogenicity substances in the biological treatment process of sewage. Water Sci Technol 47: 109116.
  • 50
    Routledge EJ, Sumpter JP. 1997. Structural features of alkylphenolic chemicals associated with estrogenic activity. J Biol Chem 272: 32803288.